Efficacy of satralizumab therapy in the treatment of NMOSD

Małgorzata Krzyżanowska; Katarzyna Kozon; Jakub Olszewski; Andrzej Patyra

doi:10.56782/pps.166

Published : 2023-09-22

Vol. 21 No. 3 (2023)

Efficacy of satralizumab therapy in the treatment of NMOSD

Małgorzata Krzyżanowska

Katarzyna Kozon

Jakub Olszewski

Andrzej Patyra

DOI: https://doi.org/10.56782/pps.166

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system and is associated with the presence of autoantibodies to anti–aquaporin-4 (AQP4-IgG). Interleukin-6 plays a key role in the pathogenesis of this disorder. Satralizumab, a humanized monoclonal antibody, targets the interleukin-6 receptor thus affecting the course of the disease. In Poland, satralizumab treatment has been offered free of charge by the public health service since November 2022. The results of SAkura studies demonstrate the long terms efficacy of satralizumab and provide evidence that satralizumab reduces the risk of relapse in patients with aquaporin-4-immunoglobulin G (IgG)–seropositive (AQP4-IgG+) NMOSD.

Keywords:

NMOSD, satralizumab, AQP4

Most read articles by the same author(s)

Katarzyna Kozon, Małgorzata Krzyżanowska, Jakub Olszewski, Andrzej Patyra, Spinal muscular atrophy – the effectiveness of treatment and new therapeutic possibilities for selected groups of patients in Poland , Prospects in Pharmaceutical Sciences: Vol. 21 No. 2 (2023)
Jakub Olszewski, Katarzyn Kozon, Andrzej Patyra, Flozins in heart failure – a new reimbursement indication , Prospects in Pharmaceutical Sciences: Vol. 20 No. 1 (2022)
Andrzej Patyra, Marcin Kołakowski, Marta Katarzyna Dudek, Anna Karolina Kiss, Isolation of trachelogenin 4-O-β-D-glucoside from the fruits of Carthamus tinctorius L. , Prospects in Pharmaceutical Sciences: Vol. 20 No. 2 (2022)
Adam Piasecki, Magdalena Sitnik, Jakub Olszewski, Maciej Bara, Katarzyna Herjan, Piotr Armański, The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Andrzej Patyra, Grzegorz Witkowski, Voltage-gated sodium channels mutations and their role in epilepsy , Prospects in Pharmaceutical Sciences: Vol. 20 No. 1 (2022)
Andrzej Patyra, Twenty years of Prospects in Pharmaceutical Sciences: recent changes , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Krzyżanowska, M., Kozon, K., Olszewski, J., & Patyra, A. (2023). Efficacy of satralizumab therapy in the treatment of NMOSD. Prospects in Pharmaceutical Sciences, 21(3), 64–68. https://doi.org/10.56782/pps.166